Showing results (11-20 of 359) with videos related to

Sort By:
Pageof 36
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 19, 2015
Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerationsAnna Sarnelli, Francesco Guerriero, Francesca Botta, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomasLisa Bodei, Daria Handkiewicz-Junak, Chiara Grana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safetyMarta Cremonesi, Mahila Ferrari, Giovanni Paganelli, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2009
Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetryCinzia Fabbri, Graziella Sarti, Marta Cremonesi, et al.
Seminars in Nuclear Medicine|January 8, 2022
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative SettingFrancesco Cicone, Anna Sarnelli, Claretta Guidi, et al.
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
Gynecologic Oncology|June 16, 2004
Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?Chiara Grana, Mirco Bartolomei, Daria Handkiewicz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposalMaria Vittoria Davì, Lisa Bodei, Marco Ferdeghini, et al.
Pageof 36